This site is intended for Healthcare Professionals only.

Voltarol introduces new ‘flip-top’ cap

Date:

Share post:

GSK, manufacturer of Voltarol, the market leading pain relief gel range in pharmacy, has re-designed the cap for its Voltarol 12 Hour Joint Pain Relief 100g Gel (2.32%). Created to help pharmacy teams support their patients in the management of hand and joint pain more effectively, the development addresses the rising trend of persistent pain and offers flip-top access to long lasting pain relief.

Voltarol 12 Hour gel provides clinically proven pain relief to patients with joint pain, delivering up to 12 hours of pain relief. The special formulation of this gel includes a permeation enhancer, which helps deliver up to 3 times more diclofenac through the skin compared to Voltarol 1% gels.

The new ‘flip-top’ packs, replacing the existing packs in the pharmacy channel from July, have a ‘one click’ design, meaning that opening with one hand or against a surface is easy. This eliminates the need for gripping or twisting, making it ideal for those whose pain affects their dexterity. As such, joint pain sufferers can access all-day relief, to help restore the joy of pain-free movement.

GSK is helping pharmacy teams fully understand joint pain and how they can help their patients treat it. For more information, please visit: www.jointpainpartners.gsk.com.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

A 5 year analysis: Rural pharmacy closures outpace openings

Findings call for more attention to rural pharmacy as only 8 opened in 2023 across the UK  The Department...

33 % rise in women seeking perinatal mental health support since 2022

One in five new and expectant mothers may be affected by perinatal mental health conditions In a significant uptick...

UK GDP Association Delivers Affordable GDP Consultancy for Small Businesses

“We want to help plug the gap where current consultancies fail these smaller businesses, and ultimately benefit UK...

Pharmacy First vital to amplify NHS digital prescription rollout, WHO report reveals

75 per cent of adults in England are registered for digital prescriptions on the NHS App In a groundbreaking...